USA Herald August 19, 2026
Moderna and Merck Cancer Vaccine Meets Phase 3 Goals in Melanoma Trial
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
USA Herald August 19, 2026
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
By David Akinwale

